A new deep learning model called ProtAttBA has been developed for predicting binding affinity changes in antibody-antigen complexes based solely on sequence information.
ProtAttBA employs pre-training on protein sequence patterns and cross-attention-based regression to make predictions.
Evaluation on three benchmarks showed competitive performance compared to traditional methods, with notable robustness even with uncertain complex structures.
The model provides interpretability through its attention mechanism, identifying critical residues affecting binding affinity, offering a rapid and cost-effective tool for antibody engineering.